Epidermal growth factor receptor (EGFR) inhibition is a good target for the treatment of diverse metastatic epithelial cancers, including lung, colon, pancreatic, and head and neck cancers [1,2,3]. The gene discussed is EGFR; the disease is head and neck cancer.